Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion type Assertion NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_head.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion description "[Patients with MBL-low genotypes also presented higher mean values for total cholesterol (228.6 vs 202.3 mg/dl, P = 0.017) and low-density lipoprotein (LDL) cholesterol (139.9 vs 121.9 mg/dl, P = 0.045), a higher frequency of chronic renal failure (30 vs 4%, P = 0.001), vasculitis (30 vs 11%, P = 0.043), heart valve lesions (71 vs 32%, P = 0.026), cardiac valve dysfunction (57 vs 7%, P = 0.0004) and associated APS (39 vs 12%, P = 0.005), a higher mean Systemic Lupus International Collaborating Clinics score (2.09 vs 1.26, P = 0.029) and a lower prevalence of low C4 levels (43 vs 71%, P = 0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_provenance.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion evidence source_evidence_literature NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_provenance.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion SIO_000772 16801331 NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_provenance.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion wasDerivedFrom befree-20150227 NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_provenance.
- NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_assertion wasGeneratedBy ECO_0000203 NP547462.RAVtoIfsRHQnU7vVgdoZBzOIfOudCeV2diA-2BJ4vZO4A130_provenance.